Integrated Device Technology (IDTI) Shares Down After Decent Earnings Report; Wall Street Firms Respond
Get Alerts IDTI Hot Sheet
Price: $48.99 --0%
Rating Summary:
12 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
12 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Integrated Device Technology (Nasdaq: IDTI) fell over 10% this morning, but shares have been making back some losses in afternoon trading. The stock is currently down 4.52%. Today's drop stems from the company's Q3 earnings report, which was issues after the bell last night.
Interestingly, third quarter results topped consensus estimates by $0.02 ($0.06 vs. Wall Street $0.04) on revenues of $120 million, which was basically in-line. Although, on a GAAP basis, continuing operations were a loss of $0.01.
Q1 guidance was between $0.02-0.04 vs. consensus of $0.04 and revenue outlook was between $114-121 mln vs. $120 mln consensus.
This morning, Canaccord Genuity reiterated a 'Buy' rating and raised its price target to $8.
Canaccord analyst, Bobby Burleson, said, "...Management sees Romley server upgrade driving better-than-seasonal revenues for Computing in the March quarter. We believe upside to our revised estimates could come from server memory interface and wireless infrastructure over the next few quarters."
Also, Barclays maintained an 'Equalweight' rating and $6 price target.
Barclays analyst, Blayne Curtis, said, "While CQ1 represents a sales bottom, we remain on the sidelines as we await evidence of IDT's potential growth drivers and operational leverage beyond the general recovery."
"Our CY12 revenue/EPS move to $504M/$0.23 ($508M/$0.29 prior) and CY13 move to $556M/$0.42 (from $552M/$0.41)."
Interestingly, third quarter results topped consensus estimates by $0.02 ($0.06 vs. Wall Street $0.04) on revenues of $120 million, which was basically in-line. Although, on a GAAP basis, continuing operations were a loss of $0.01.
Q1 guidance was between $0.02-0.04 vs. consensus of $0.04 and revenue outlook was between $114-121 mln vs. $120 mln consensus.
This morning, Canaccord Genuity reiterated a 'Buy' rating and raised its price target to $8.
Canaccord analyst, Bobby Burleson, said, "...Management sees Romley server upgrade driving better-than-seasonal revenues for Computing in the March quarter. We believe upside to our revised estimates could come from server memory interface and wireless infrastructure over the next few quarters."
Also, Barclays maintained an 'Equalweight' rating and $6 price target.
Barclays analyst, Blayne Curtis, said, "While CQ1 represents a sales bottom, we remain on the sidelines as we await evidence of IDT's potential growth drivers and operational leverage beyond the general recovery."
"Our CY12 revenue/EPS move to $504M/$0.23 ($508M/$0.29 prior) and CY13 move to $556M/$0.42 (from $552M/$0.41)."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
- Utah Medical Products (UTMD) Reports Q1 EPS of $1.10
Create E-mail Alert Related Categories
Analyst Comments, EarningsRelated Entities
Barclays, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!